GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...
When it comes to weight loss, we've all been told that eating a healthy, balanced diet holds the key to success. But for many ...
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...
Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.
Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...
It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...
GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...
The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...
Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...
Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform committed to breaking down ...